Lecanemab in Early Alzheimer's Disease.
Randomized controlled trial · N Engl J Med · 2023. Source record refreshed; an explanation has not been reviewed.
About this paper
This page identifies the publication and its source. A checked explanation of its findings is not yet available.
Reading this record
Checking bibliographic metadata does not verify a study’s conclusions or any advice previously linked to it.
Publication details
Lecanemab in Early Alzheimer's Disease.
van Dyck CH, Swanson CJ, Aisen P et al.
N Engl J Med · 2023
- PubMed ID
- 36449413
- Record checked
Linked publication notices
- Comment In ↗
- Comment In ↗
- Comment In ↗
- Comment In ↗
- Comment In ↗
- Comment In ↗
- Comment In ↗
- Comment In ↗
- Comment In ↗
- Comment In ↗
- Comment In ↗
- Comment In ↗
- Comment In ↗
- Comment In ↗
A checked publication record confirms source details. It does not verify a health claim or assess the quality of the study. Our approach.
Keep your place in the research.
Save this source or mark it as read.